Reemplazo hormonal para hipogonadismo masculino

¹Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS and Montori VM.  Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, June 2010, Vol. 95(6):2536–2559. Disponible en: http://www.endo-society.org/guidelines/Current-Clinical-Practice-Guidelines.cfm
²Dandona P, Rosemberg MT. A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract, May 2010, 64, 6, 682–696. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948422/pdf/ijcp0064-0682.pdf
³Morales A, Shulman CC, Tostain J, Wu, FCW. Testosterone Deficiency Syndrome (TDS) Needs to be Named
Appropriately – The Importance of Accurate Terminology. European Urology  2006; 50: 407–409 Disponible en: http://www.muzhskoydoctor.ru/files/tds.pdf
⁴Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ,  KaufmanJM, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. International Journal of Impotence Research (2009) 21, 1–8; doi:10.1038/ijir.2008.41; published online 16 October 2008. Disponible en: http://www.nature.com/ijir/journal/v21/n1/full/ijir200841a.html
⁵Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al.  Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002 Feb;87(2):589-98. Disponible en: http://press.endocrine.org/doi/full/10.1210/jcem.87.2.8201
⁶Harman SM, Metter J, Tobin JD, Pearson J, Blackman MR. Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men.  J Clin Endocrinol Metab. 2011 Feb;86(2):724-31 Disponible en: http://press.endocrine.org/doi/full/10.1210/jcem.86.2.7219
⁷Liverman CT, Blazer DG. Testosterone and Aging Clinical Research Directions. Institute of Medicine of the National Academies. The National Academy Press. Washington DC. 2004.  Executive summary disponible en: http://www.usrf.org/news/IOMT-reportExecSummary.pdf
⁸Bolona ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, Caples SM, Erwin PJ, Montori VM. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clinic Proceedings 2007; 82(1): 20-28
⁹Fernández-Balsells HM, Murad MH, Melanie L, Lampropulos JF, Albuquerque F, Erwin PJ, Bhasin S, Montori VM 2010 A dverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin E ndocrinol Metab, 95(6):2560–2575. Disponible en: http://press.endocrine.org/doi/full/10.1210/jc.2009-2575
¹⁰Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism
in males. Int J Impotence Research. 2009; 21:1-8. Disponible en: http://www.nature.com/ijir/journal/v21/n1/full/ijir200841a.html
¹¹Yassin AA, Doros G. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clinical obesity. 2013. International Association for the study of obesity.
¹²Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity 2013.